0Q4U.LSE News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

Loading chart

Pay with

0Q

Mkt Cap

N/A

Volume

290.26K

Next Earnings

N/A

Chart Earnings News About Dividends Insider Filings

Resolutions from the Annual General Meeting 2025Novonesis (Novozymes A/S) Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2024 Approval of distribution of profit with payment of an ordinary dividend of DKK 4.20 (corresp…finance.yahoo.com · Apr 3, 2025

Election of employee representatives to the Board of DirectorsNovonesis (Novozymes A/S) The employees have conducted the election of employee representatives to the Board of Directors of Novonesis (Novozymes A/S). The following employee representatives (in alphabetical order after surname) were elected for the next four years: Robert Nøddes…finance.yahoo.com · Mar 5, 2025

Initiation of share buyback programNovonesis (Novozymes A/S) On March 5, 2025, Novonesis will initiate a share buyback program as announced in Company Announcement No. 3 of February 26, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million in total during the remainder of 2025, corr…finance.yahoo.com · Mar 5, 2025

12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025Novonesis (Novozymes A/S) Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of 37-38%. COPENHAGEN, Denmark – February 26, 2025. In the 202…finance.yahoo.com · Feb 26, 2025

12M 2024 Company announcementNovonesis (Novozymes A/S) 2024 organic pro forma sales growth of 8%, with pro forma adjusted EBITDA margin of 36.1%. 2025 outlook of 5-8% organic pro forma sales growth and 37-38% adjusted EBITDA margin. 2024 organic pro forma sales growth of 8% (Q4: 7%) and 8% on IFRS reported b…finance.yahoo.com · Feb 26, 2025

Change to the Executive Leadership TeamNovonesis (Novozymes A/S) Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025. Ester Baiget, President & CEO comments:“I want to thank Jacob for his…finance.yahoo.com · Feb 21, 2025

Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme AllianceNovonesis (Novozymes A/S) Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collabor…finance.yahoo.com · Feb 11, 2025

Resolutions from the Extraordinary Shareholders’ Meeting 2024Company Announcement no. 10 March 4, 2024 Today an extraordinary shareholders’ meeting was conducted. The following resolutions were made: Adoption of Novonesis A/S as secondary name and amendment of the Articles of Association in accordance herewith Election of Jesper Brandgaard…finance.yahoo.com · Mar 4, 2024

Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completedNovozymes A/S Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024 Company announcement No. 07 On January 29, 2024, following the satisfaction of all conditions precedent, the combination of Novozymes A/S ("Novozymes") and Chr…finance.yahoo.com · Feb 2, 2024

Legacy Novozymes delivers solid last full-year resultsNovozymes A/S Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, N…finance.yahoo.com · Feb 1, 2024

to start trading

0Q

0Q4U.LSE0Q4U.LSE

0Q4U.LSE

Pay with—

Available Balance0.00

Your PositionYou don't own any 0Q4U.LSE yet.

Related Tickers

Earnings

Dividends

Last · Aug 25Semi-annual

Amount$2.35

Yield1.45%

Annual$6.60